Analyst Ratings for Zimmer Biomet Holdings
Portfolio Pulse from Benzinga Insights
Analysts have provided various ratings for Zimmer Biomet Holdings (NYSE:ZBH) in the last quarter, with 1 bullish, 2 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The company has an average 12-month price target of $142.75, up by 1.67% from the previous average of $140.40.
October 02, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Zimmer Biomet Holdings has received mixed ratings from analysts, with an average 12-month price target of $142.75.
The mixed analyst ratings indicate uncertainty about the company's performance. However, the increase in the average price target suggests a positive outlook.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100